Japet Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
41
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$531K
- Investors
-
12
Japet General Information
Description
Developer of wearable robotic exoskeletons designed for occupational and daily health. The company's exoskeletons combine medical and robotic technology for motion that helps to restore the body's balance for free movement, and provides pain relief using orthosis, enabling customers to eliminate lower pain and carry out movements.
Contact Information
Website
www.japet.euCorporate Office
- 147 Avenue Pierre Mauroy
- 59120 Loos
- France
Corporate Office
- 147 Avenue Pierre Mauroy
- 59120 Loos
- France
Japet Timeline
Japet Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 07-Jun-2024 | $531K | Completed | Generating Revenue | ||
| 10. Equity Crowdfunding | 07-Jun-2024 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A) | 10-Jul-2023 | Completed | Generating Revenue | |||
| 8. Equity Crowdfunding | 10-Jul-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Aug-2021 | Completed | Generating Revenue | |||
| 6. Grant | 20-Apr-2020 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 4. Seed Round | 16-Oct-2017 | Completed | Startup | |||
| 3. Accelerator/Incubator | 27-Jul-2016 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup |
Japet Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| AP 2021 | ||||||||
| Series A | ||||||||
| AP 2021 | 12,854 | $1.084135 | $248.18 | $248.18 | 1x | $248.18 | 36.29% | |
| Category AP | 4,069 | $1.084135 | $136.6 | $136.6 | 1x | $136.6 | 11.49% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Japet Patents
Japet Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3285702-B1 | Device for vertebral decompression | Active | 20-Apr-2015 | ||
| EP-3285702-C0 | Device for vertebral decompression | Active | 20-Apr-2015 | ||
| ES-3008100-T3 | Device for vertebral decompression | Active | 20-Apr-2015 | ||
| JP-6923448-B2 | Spine decompression device | Active | 20-Apr-2015 | ||
| JP-2018516640-A | Spine decompressor | Active | 20-Apr-2015 | A61F5/028 |
Japet Signals
Japet Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angelor | Venture Capital | Minority | ||
| Tudigo | Venture Capital | Minority | ||
| 5M Ventures | VC-Backed Company | Minority | ||
| Boundary Holding | Venture Capital | Minority | ||
| EIT Health | Accelerator/Incubator |
Japet FAQs
-
When was Japet founded?
Japet was founded in 2015.
-
Where is Japet headquartered?
Japet is headquartered in Loos, France.
-
What is the size of Japet?
Japet has 41 total employees.
-
What industry is Japet in?
Japet’s primary industry is Therapeutic Devices.
-
Is Japet a private or public company?
Japet is a Private company.
-
What is the current valuation of Japet?
The current valuation of Japet is .
-
What is Japet’s current revenue?
The current revenue for Japet is .
-
How much funding has Japet raised over time?
Japet has raised $8.88M.
-
Who are Japet’s investors?
Angelor, Tudigo, 5M Ventures, Boundary Holding, and EIT Health are 5 of 12 investors who have invested in Japet.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process